Clinical Trial Update: Prevention of Kidney Transplant Rejection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating prevention of kidney transplant rejection has completed; sponsored by NIAID, involving patients with end-stage renal disease and chroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allograft Nephropathy
• End-stage Renal Disease

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: End-Stage Renal Disease, Chronic Allograft Nephropathy | Phase 3 | Status: COMPLETED